Dr Reddys reported flat QoQ sales in 3QFY16. EBITDA margins saw a sequential decline of 242bps because of the ongoing remediation measures. Settlement charges of US$ 5.5mn related to Reclast and forex loss of Rs 637mn in Venezuela hit reported net profit (down 20% QoQ, flat YoY).